Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda

Published:2023-12 Issue:50 Volume:41 Page:7573-7580
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Man-Lik Choi Edward,Abu-Baker Mustapher Ggayi,Omosa-Manyonyi Gloria,Foster Julie,Anywaine Zacchaeus^ORCID,Musila Mutua Michael,Ayieko Philip,Vudriko Tobias,Ann Mwangi Irene,Njie Yusupha,Ayoub Kakande^ORCID,Mundia Muriuki Moses,Kasonia Kambale^ORCID,Edward Connor Nicholas,Florence Nambaziira,Manno Daniela,Katwere Michael,McLean Chelsea^ORCID,Gaddah Auguste^ORCID,Luhn Kerstin^ORCID,Lowe Brett,Greenwood Brian,Robinson Cynthia,Anzala Omu,Kaleebu Pontiano,Watson-Jones Deborah

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference15 articles.

1. ICTV virus taxonomy profile: filoviridae;Kuhn;J Gen Virol,2019

2. Ebola virus disease;Jacob;Nat Rev Dis Primers,2020

3. World Health Organization. Ebola virus disease [updated 2021 Feb 2Available from: https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease.

4. Anywaine ZM, G.A. African Cities and Urban Health. Handbook of Global Urban Health: Routledge; 2019.

5. First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response [press release]. 2019 Dec 19 2019.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP